Fingerprint
Dive into the research topics of 'Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically